APR 01, 2021 7:00 AM PDT

The Curious Case of COVID Immunity...a Threat to Vaccination Efforts?

WRITTEN BY: Tara Fernandez

After COVID infection, there’s a spectrum of diversity in how long antibodies against the coronavirus hang around—anywhere from days to years. A recent study indicates that the persistence of antibodies against SARS-CoV-2 may be linked to the severity of the infection that the patient experienced, with important implications to vaccination strategies.

The team of scientists from Duke-NUS tracked a cohort of 164 COVID-19 patients in Singapore over a period of around half a year. During this time, they took blood samples to map the dynamics of virus-neutralizing antibodies and other immune factors. This dataset was used to build a machine learning algorithm for predicting how long-lasting a patient’s antibodies to the coronavirus are likely to be.

“The key message from this study is that the longevity of functional neutralizing antibodies against SARS-CoV-2 can vary greatly, and it is important to monitor this at an individual level. This work may have implications for immunity longevity after vaccination, which will be part of our follow-up studies,” said the study’s corresponding author, infectious disease expert Wang Linfa.

Wang and the team were able to classify patients according to their antibody responses. Around 11 percent of patients did not develop any neutralizing antibodies to the coronavirus. Then there was the “rapid waning” group (26.8 percent), whose antibodies dropped off in a matter of days. The “slow waning” and “persistent” groups maintained neutralizing antibodies (at varying levels) for about six months. A small percentage of patients had a “delayed response,” with antibody levels spiking much later during the recovery period.

For the patients without an observable antibody response, the scientists showed that T cell immunity played a larger role in protecting these individuals.

“Our study examines neutralizing antibodies which are important in protection from COVID-19,” explained corresponding author David Lye. “We found that antibodies against SARS-CoV-2 wane in different people at different rates. This emphasizes the importance of public health and social measures in ongoing pandemic outbreak response.” 

“However, the presence of T-cell immunity provides hope of longer-term protection, which will require more studies and time for epidemiological and clinical evidence to confirm,” added Lye.

According to the authors, this study's results could have important implications on vaccination strategies and other government-led initiatives to return to pre-pandemic normalcy. Differences in antibody waning rates could mean that reinfection is a genuine threat for some, even with natural or vaccine-induced immunity. Additionally, if this tapering of antibody levels occurs in those vaccinated, then annual COVID vaccine rollouts could be necessary to maintain herd immunity.

 



Sources: The Lancet Microbe, Duke-NUS Medical School.

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
JUN 08, 2021
Immunology
Is the Pfizer-BioNtech Vaccine Variant-Resistant?
JUN 08, 2021
Is the Pfizer-BioNtech Vaccine Variant-Resistant?
Genetic variants of SARS-CoV-2 have emerged over the course of the pandemic, threatening public health efforts to limit ...
JUL 01, 2021
Immunology
Simple Dietary Changes Could Help Ease Skin and Joint Inflammation
JUL 01, 2021
Simple Dietary Changes Could Help Ease Skin and Joint Inflammation
Eating too much sugar and fat can have a dramatic impact on the gut microflora, which in turn can flare up inflammatory ...
JUL 18, 2021
Cancer
Light Alcohol Use Linked to Higher Cancer Risk
JUL 18, 2021
Light Alcohol Use Linked to Higher Cancer Risk
Moderate alcohol use is linked to a substantially higher risk of several forms of cancer, including breast, colon, and o ...
AUG 25, 2021
Cell & Molecular Biology
Sino Biological's Listing on the Shenzhen Stock Exchange
AUG 25, 2021
Sino Biological's Listing on the Shenzhen Stock Exchange
China, August 16, 2021 - Sino Biological, Inc. (“Sino Biological” or the “Company”), a biot ...
SEP 08, 2021
Health & Medicine
Gene Linked to Endometriosis Could Lead to Non-Hormonal Treatment Options
SEP 08, 2021
Gene Linked to Endometriosis Could Lead to Non-Hormonal Treatment Options
Researchers from the University of Oxford found an association between neuropeptide S receptor 1 (NPSR1) gene variants a ...
SEP 14, 2021
Drug Discovery & Development
A novel drug that targets the removal of pathogenic antibodies in myasthenia gravis
SEP 14, 2021
A novel drug that targets the removal of pathogenic antibodies in myasthenia gravis
Myasthenia gravis is a chronic autoimmune disorder characterized by muscle weakness and fatigue. The disorder leads to a ...
Loading Comments...